Feature|Articles|August 30, 2024

New Treatments Are Changing the Future of Alzheimer Disease

Author(s)Aislinn Antrim, Associate Editorial Director

Despite questions and controversy around some clinical research, new understandings of the pathophysiology of the disease are pushing treatments forward.

Recent FDA approvals and new scientific understandings have given patients and practitioners renewed hope for the future of Alzheimer disease (AD), which has long presented a challenge. As new treatments finally reach the public, pharmacists will play a growing role in counseling and ensuring patient access.